ESTRO 2025 - Abstract Book

S841

Clinical - Gynaecology

ESTRO 2025

years, 45.6% for 60-69 years and 21.9% for ≥70 years; p<0.001). Furthermore, older patients rated both treatment duration (p=0.001) and long-term tingling or numbness (p=0.005) as significantly more important than their younger counterparts (Figure 2).